Mirae Asset Global ETFs Holdings
TBPH icon

Mirae Asset Global ETFs Holdings’s Theravance Biopharma TBPH Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$577K Sell
33,941
-8,725
-20% -$144K ﹤0.01% 1923
2026
Q1 		$692K Buy
42,666
+4,496
+12% +$79.5K ﹤0.01% 1706
2025
Q4 		$714K Buy
38,170
+559
+1% +$9.27K ﹤0.01% 1707
2025
Q3 		$549K Sell
37,611
-1,435
-4% -$18.1K ﹤0.01% 1828
2025
Q2 		$431K Sell
39,046
-1,297
-3% -$12.6K ﹤0.01% 1896
2025
Q1 		$360K Buy
40,343
+540
+1% +$5.03K ﹤0.01% 2037
2024
Q4 		$375K Buy
39,803
+592
+2% +$5.39K ﹤0.01% 2063
2024
Q3 		$316K Sell
39,211
-4,055
-9% -$35.1K ﹤0.01% 2138
2024
Q2 		$367K Buy
+43,266
New +$390K ﹤0.01% 1960

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TBPH Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Theravance Biopharma (TBPH) stake by 20% in Q2 2026, selling an estimated $144K and leaving 33,941 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Mirae Asset Global ETFs Holdings first reported a position in TBPH in Q2 2024 and has held it in 9 quarters since. The position peaked at $714K in Q4 2025. 179 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 33,941 shares of Theravance Biopharma worth $577K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 8,725 Theravance Biopharma shares in Q2 2026, an estimated $144K.
  • Theravance Biopharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1923 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Theravance Biopharma in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Theravance Biopharma position peaked at $714K in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.